Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

UNCY US Equity

Unicycive Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1766140 · FY ends Dec 31
$5.58
-0.05 (-0.89%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 4 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Nantahala Capital Management, LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Vivo Opportunity Fund Holdings, L.P.sec.gov ↗
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-3013GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by INTEGRATED CORE STRATEGIES (US) LLCsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-08

Every row is a filed document, checked against its EDGAR index.